Approval · Notice of Compliance 11218 · 2010
METFORMIN: Notice of Compliance 11218
Issued April 1, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11218
- Date
- April 1, 2010
- Company
- Sorres Pharma IncMontreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer and product name change
- Therapeutic class
- Antihyperglycemic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| METFORMIN | 02242793 | Cancelled Post Market |
Medicinal ingredients
- METFORMIN HYDROCHLORIDE 850 MG per TAB